76 results on '"de Vries, F"'
Search Results
2. His452Tyr 5-HT2A polymorphism and intravaginal ejaculation latency time in Dutch men with lifelong premature ejaculation
3. Impact of COVID-19 lockdown on physical activity and sedentary behaviour in Dutch cardiovascular disease patients
4. Glucose-Lowering Drugs and Fracture Risk—a Systematic Review
5. The risk of new fragility fractures in patients with chronic kidney disease and hip fracture—a population-based cohort study in the UK
6. Global plant trait relationships extend to the climatic extremes of the tundra biome
7. Long-term outcomes after contaminated complex abdominal wall reconstruction
8. The development and validation of risk-stratification models for short-term outcomes following contaminated complex abdominal wall reconstruction
9. Diabetes and fractures: new evidence of atypical femoral fractures?
10. Two-year persistence with teriparatide improved significantly after introduction of an educational and motivational support program
11. All-cause mortality with current and past use of antidepressants or benzodiazepines after major osteoporotic and hip fracture
12. Association between use of antidepressants or benzodiazepines and the risk of subsequent fracture among those aged 65+ in the Netherlands
13. Incidence of subsequent fractures in the UK between 1990 and 2012 among individuals 50 years or older
14. Use of systemic glucocorticoids and the risk of major osteoporotic fractures in patients with sarcoidosis
15. Closed incision prophylactic negative pressure wound therapy in patients undergoing major complex abdominal wall repair
16. Risk of infections in patients with gout: a population-based cohort study
17. The Netherlands Chlamydia cohort study (NECCST) protocol to assess the risk of late complications following Chlamydia trachomatis infection in women
18. The epidemiology of mortality after fracture in England: variation by age, sex, time, geographic location, and ethnicity
19. Secular trends in fracture incidence in the UK between 1990 and 2012
20. The epidemiology of fractures in Denmark in 2011
21. Risk of vertebral and non-vertebral fractures in patients with sarcoidosis: a population-based cohort
22. Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000–2010
23. Long-term persistence with anti-osteoporosis drugs after fracture
24. Ankylosing spondylitis confers substantially increased risk of clinical spine fractures: a nationwide case-control study
25. The risk of major and any (non-hip) fragility fracture after hip fracture in the United Kingdom: 2000–2010
26. Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications
27. Risk of fracture in patients with Guillain-Barré syndrome
28. Incidence Rates and Trends of Hip/Femur Fractures in Five European Countries: Comparison Using E-Healthcare Records Databases
29. Excess risk of hip fractures attributable to the use of antidepressants in five European countries and the USA
30. Elevated risk of clinical fractures and associated risk factors in patients with systemic lupus erythematosus versus matched controls: a population-based study in the United Kingdom
31. Increase in prophylaxis of glucocorticoid-induced osteoporosis by pharmacist feedback: a randomised controlled trial
32. Risk of fracture in patients with muscular dystrophies
33. Urban and agricultural soils: conflicts and trade-offs in the optimization of ecosystem services
34. Risk of fracture in patients with Parkinson’s disease
35. Potential Impact of Benzodiazepine Use on the Rate of Hip Fractures in Five Large European Countries and the United States
36. Fracture rate in patients with myasthenia gravis: the general practice research database
37. Calibration of FRAX ® 3.1 to the Dutch population with data on the epidemiology of hip fractures
38. Complications due to bovine pericardium used to cover acrylic implants after enucleation and tubes of aqueous devices
39. Dopaminergic drugs and the risk of hip or femur fracture: a population-based case–control study
40. Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study
41. Proton pump inhibitors, fracture risk and selection bias: three studies, same database, two answers
42. Fracture risk in patients receiving acid-suppressant medication alone and in combination with bisphosphonates
43. Use of anti-depressants and the risk of fracture of the hip or femur
44. Use of anti-depressants and the risk of fracture of the hip or femur
45. Antipsychotic use and the risk of hip/femur fracture: a population-based case–control study
46. Heavy-Metal Concentrations in Small Mammals from a Diffusely Polluted Floodplain: Importance of Species- and Location-Specific Characteristics
47. Use of β-Blockers and the Risk of Hip/Femur Fracture in the United Kingdom and The Netherlands
48. Interleukin 10: a new risk marker for the development of restenosis after percutaneous coronary intervention
49. Integrating “livelihoods” into integrated water resources management: taking the integration paradigm to its logical next step for developing countries
50. Within-trophic group interactions of bacterivorous nematode species and their effects on the bacterial community and nitrogen mineralization
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.